Temporal changes in treatment patterns by age group and functional status before and after PD-1/L1 inhibitor approvals in advanced urothelial carcinoma

IntroductionMetastatic urothelial carcinoma (mUC) has poor prognosis. A high unmet need exists for novel treatment for those who are unfit for platinum-based chemotherapy.MethodsWe aimed to describe real-world temporal changes in patient characteristics and 1L treatment selection for mUC patients in...

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	Gurjyot K. Doshi, Haojie Li, Mehmet Burcu, Srinivas Annavarapu, Karen Wells, Kentaro Imai, Blanca Homet Moreno, Puneet Singhal, Ronac Mamtani
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-10-01
Subjects:	treatment pattern advanced urothelial carcinoma real-world observational study US immunotherapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1210208/full